Session Recap: Viewing Unusual Volume for Cymabay Therapeutics, Inc. (NASDAQ:CBAY)

Oppenheimer Holdings, Inc. began coverage on shares of CymaBay Therapeutics in a research note on Friday, June 23rd. The stock exchanged hands 10.63 Million shares versus average trading capacity of 602.46 Million shares, yielding a market cap of $217.56 Million. The stock hit its 52-week high on 07/17/17, and 52-week low on 11/09/16.

Cymabay Therapeutics, Inc. (NASDAQ:CBAY) stock is experiencing unusual volume during today's trading.

Cymabay Therapeutics (NASDAQ:CBAY)'s trailing twelve month revenues are $4.8 Million, whereas its price to sales ratio for the same period is 45.33. Where the relative strength index (RSI) is a technical momentum indicator that compares the magnitude of recent gains to recent losses in an attempt to determine excess buying & selling conditions of an asset, it is one of the most popular technical indicators, computed on the basis of the speed and direction of a stock's price movement. (NASDAQ:CBAY)'s stock about -3.60% from the 50-day high and 122.26% away from the 50-day low. A negative earnings surprise will usually result in a decline in share price. "(CBAY) Given a $7.00 Price Target by Piper Jaffray Companies Analysts" was posted by The Cerbat Gem and is the property of of The Cerbat Gem. Analysts forecast that CymaBay Therapeutics will post ($0.83) EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: "CymaBay Therapeutics Inc. (CBAY) Receives Outperform Rating from Citigroup Inc." was published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of US & global copyright and trademark law. The original version of this news story can be viewed at

Institutional investors have recently added to or reduced their stakes in the company. LVM Capital Management Ltd. MI raised its position in shares of CymaBay Therapeutics by 100.0% in the second quarter. Over the past month the firm's stock is 1.16%, -2.97% for the last quarter, 2.35% for the past six-months and -23.24% for the a year ago. ClariVest Asset Management LLC bought a new position in CymaBay Therapeutics during the first quarter worth approximately $105,000. TFS Capital LLC purchased a new position in shares of CymaBay Therapeutics during the first quarter worth approximately $169,000. Finally, Renaissance Technologies LLC boosted its position in CymaBay Therapeutics by 97.6% in the first quarter. Over the past month the firm's stock is 46.81%, 89.95% for the last quarter, 310.58% for the past six-months and 349.39% for the previous year. CymaBay Therapeutics earned a daily sentiment score of 0.35 on Accern's scale. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. Arhalofenate is used to treat gout.

Like this


21 July 2017
RB Chris Johnson re-signs for third season with Cardinals
Now Chris Johnson will be fighting for reps in training camp behind David Johnson, Ellington, rookie TJ Logan and others. Johnson burst onto the NFL's radar in the spring of 2008 by setting a combine record with a 4.24 second 40-yard dash.

21 July 2017
First BanCorp. (NYSE:FBP) Position Boosted by Fmr LLC
The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website . The bank reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.01.

21 July 2017
Watts Water Technologies (NYSE:WTS) Receives Daily Media Impact Rating of 0.22
The technology company reported $0.65 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.60 by $0.05. Other hedge funds have also added to or reduced their stakes in the company. 30 funds opened positions while 46 raised stakes.

21 July 2017
Electro Scientific Industries (ESIO) Earning Somewhat Positive Press Coverage, Analysis Shows
Analysts expect Electro Scientific Industries , Inc. (NASDAQ: ESIO ) has risen 19.94% since July 19, 2016 and is uptrending. It has outperformed by 3.24% the S&P500.The move comes after 6 months positive chart setup for the $300.85 million company.

21 July 2017
Wipro beats first-quarter estimates, posts consolidated profit of Rs 2083 crore
How the company manages its EBIT margins through cost control and without lack of one-time items in fourth quarter FY17. Hearteningly for Wipro , some of the new initiatives undertaken by Neemuchwala appear to be finally showing results.

21 July 2017
Middletown man in trouble for leaving dog in hot vehicle again
Middletown Police Lieutenant Heather Desmond says this is not the first time the 79-year-old has caused a dog to die in that way. A Wesleyan University professor emeritus has been arrested after leaving a dog to die in his auto on a hot day.

21 July 2017
Kyle Pitts, 4-Star TE, Commits To Florida On Roller Coaster
Pitts, a four-star prospect according to 247Sports Composite, is the No. 11 TE and the No. 252 overall player in the 2018 class. Pitts, who is a standout at Archbishop Wood in Warminster, Penn., is now rated as the No. 7 tight end recruit in the nation.

20 July 2017
'Unbelievable': Trump Slams Sessions' Recusal; Warns Mueller to Steer Clear of Finances
Trump told The New York Times Wednesday he never would have picked Sessions had he known a recusal was coming. The adviser said the remarks were not meant to signal that Trump plans to fire Sessions.

20 July 2017
Amit Shah to visit Rajasthan tomorrow
Shah will inaugurate an e-library at the state party office and then hold a meeting with ministers of the Rajasthan government. Late Thursday night, Parnami issued a statement cancelling the appointments citing constitutional restrictions.

20 July 2017
Duke and Duchess to meet Holocaust survivors in Poland
He added, "I decided that I really had to face the past and hence my consent to come". Mr Goldberg said they were regularly forced to watch public executions.